SEATTLE, May 2, 2011 /PRNewswire/ -- On Tuesday, May 3, 2011, at 8:30 a.m. Eastern Time/2:30 p.m. Central European Time/5:30 a.m. Pacific Time, members of Cell Therapeutics, Inc.'s (CTI) (NASDAQ and MTA: CTIC) management team will host a conference call to provide an update on the Company, including a discussion of pixantrone.
Conference Call Numbers
Tuesday, May 3
8:30 a.m. Eastern Time/2:30 p.m. Central European Time/5:30 a.m. Pacific Time
1-877-941-9205 (US Toll-Free)
1-480-629-9835 (US Local)
800-149-070 (Italy Toll-Free)
39-023-0350-9038 (Italy Local)
Call-back numbers for post-listening available at 11:30 a.m. Eastern Time:
1-800-406-7325 (US)
1-303-590-3030 (International)
Passcode: 4438455#
Live audio webcast at www.celltherapeutics.com will be archived for post listening approximately two hours after call ends.
Media Contact: Dan Eramian T: 206.272.4343 C: 206.854.1200 F: 206.272.4434 E: deramian@ctiseattle.com www.celltherapeutics.com/press_room | Investors Contact: Ed Bell T: 206.272.4345 Lindsey Jesch Logan T: 206.272.4347 F: 206.272.4434 E: invest@ctiseattle.com www.celltherapeutics.com/investors | |
SOURCE Cell Therapeutics, Inc.
